DALLAS, June 2 /PRNewswire/ -- BeaconEquity.com announces the availability of TraderNotes on stocks that are making news today.
Investors can view all of the daily trading notes for free by visiting: http://www.BeaconEquity.com/m
Today's TraderNotes include: TapImmune Inc. (OTC Bulletin Board: TPIM), RXi Pharmaceuticals Corp. (Nasdaq: RXII), Vion Pharmaceuticals Inc. (Nasdaq: VION), Neuralstem Inc. (Amex: CUR), Amgen Inc. (Nasdaq: AMGN), Gilead Sciences Inc. (Nasdaq: GILD), Biogen Idec Inc. (Nasdaq: BIIB) and Genaera Corp. (Nasdaq: GENR).
Join the investor discussion surrounding TPIM at: http://www.stocknetworkonline.com/
BeaconEquity.com's TraderNotes are brief analyses on the active stocks each day that are affecting the markets. These include breaking news, insider activity, recent 52-week highs/lows, technical breakouts, and other market driving information. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas by visiting: http:/BeaconEquity.com/m
BeaconEquity.com is one of the industry's largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://BeaconEquity.com/m. CRD# 1755680.
The companies that are discussed have not always approved the
statements made in this opinion. These reports are for informational
purposes only and should not be construed as an offer or solicitation of an
offer to buy or sell any securities mentioned. We are not a licensed or
registered broker dealer, investment advisor, analyst or underwriter.
Please consult a registered broker before purchasing or selling any
securities viewed or mentioned here. BER and its affiliates have been
compensated forty seven thousand five hundred dollars from non-controlling
third party (StocksJournal) for the enrollment of TPIM in its research
Beacon Equity Research
Jeff Bishop, (469)-252-3505
Reuben Sushman of Beacon Equity Research is a member of the National
Association of Securities Dealers, CRD number 1755680.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. JEFF BISHOP http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=70781
Copyright©2008 PR Newswire.
All rights reserved